This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medical Action Industries Reports First Quarter Fiscal Year 2014 Results

BRENTWOOD, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the first quarter ended June 30, 2013, including net sales of $107.2 million and gross profit of $17.7 million or 16.5% of net sales. The Company generated net income of $0.3 million or $0.02 per diluted share and EBITDA, as adjusted of $4.5 million. The reported gross profit, net income and EBITDA, as adjusted results represent increases versus the comparable results for the same period of fiscal year 2013.

Paul D. Meringolo, Chief Executive Officer, said, "As in recent quarters, our cost savings initiatives, the elimination of unprofitable sales and a reduction in raw material costs continue to be the key drivers behind the profitability improvements we are reporting today. I am extremely pleased at our management team's ability to manage these improvements without compromising their focus on delivering exceptional service and value to our customers. I continue to be excited about the numerous obtainable profit improvement initiatives we have identified which should yield further near-term improvement in financial results and continue to enhance stockholder value."

First Quarter Results of Fiscal Year 2014

Net sales for the first quarter of fiscal year 2014 were $107.2 million, down $5.0 million or 4.5% from net sales of $112.2 million for the first quarter of fiscal year 2013. This decrease results in part from management's efforts to focus on profitable business and to decrease or eliminate unprofitable or non-core sales. The reported gross profit of $17.7 million, or 16.5% of net sales, represents an improvement over the gross profit reported in the prior year period of $16.9 million or 15.1% of net sales. This improvement in gross profit is the result of management's cost savings initiatives, elimination of unprofitable sales and a reduction in raw material costs.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.56 +15.31 0.73%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs